Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

VEXAS syndrome News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

VEXAS syndrome: a rare disease requiring an inherently interprofessional approach.

The Groupe Francophone des Myélodysplasies has released new recommendations for the diagnostic approach and management of myelodysplastic syndromes, chronic myelomonocytic leukemias, and VEXAS syndrome. These guidelines aim to improve clinical outcomes and standardize treatment protocols.

A recent study explores the clinical and molecular spectrum of VEXAS syndrome associated with multiple UBA1 variants. This case study contributes to the understanding of the disease's genetic underpinnings and clinical manifestations.

A new study presents an Italian cartography of thrombosis related to VEXAS syndrome, enhancing understanding of this rare disease. The findings may inform future research and clinical approaches to managing VEXAS-related complications.

A comprehensive review on VEXAS syndrome provides insights into its work-up, diagnosis, treatment, and prognosis. This resource is essential for dermatologists to enhance their understanding and management of this rare disease.

A case report details the first documented instance of VEXAS syndrome in Lebanon, highlighting the efficacy of Azacitidine as a therapeutic option. This adds to the understanding of VEXAS syndrome and potential treatment pathways.

A case report highlights cryptococcal meningitis in a patient with VEXAS syndrome, contributing to the understanding of complications associated with this rare disease. This study underscores the need for awareness and management strategies for infections in patients with VEXAS syndrome.

Recent research highlights the role of inflammatory cell death and monocyte dysfunction in VEXAS syndrome. This study provides insights into the underlying mechanisms of the disease, potentially guiding future therapeutic strategies.

Not rare diseases news,news about your rare disease.